Cargando…
Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies
In developed countries, hematological malignancies (HM) account for 8 to 10% of cancers diagnosed annually and one-third of patients with HM (HMP) are expected to die from their disease. The former wide spectrum “magic bullet,” imipenem, has been ousted by the emergence of carbapenem resistant (CR)...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379235/ https://www.ncbi.nlm.nih.gov/pubmed/32765433 http://dx.doi.org/10.3389/fmicb.2020.01422 |